A A A
MENU

Arrhythmia Alliance News & Events

PATIENT DIES AFTER BEING DENIED ACCESS TO LIFE-SAVING TREATMENT DUE TO LACK OF NHS FUNDING

Arrhythmia Alliance is calling on NHS England to reconsider its ‘Commissioning through Evaluation’ (CtE) process, following the death of a high risk atrial fibrillation (AF) patient from a bleed to the brain after being refused a potentially life-saving treatment. The evaluation process of left atrial appendage occlusion (LAAO), a treatment approved by the FDA and used across Europe, has meant hundreds of patients being denied access to this treatment with no guarantee when the evaluation will be completed to allow access.

Read full press release here

Share

Send us your feedback

Download Resource

To download our information resource and receive regular updates from Arrhythmia Alliance please enter your details below*:

No thanks

*Please note you can unsubscribe from our mailing list at any time

This link will take you to the site

Stay on this site